Call for papers - Incretins and incretin-based therapies for obesity, diabetes and other metabolic disorders

Nicolai Wewer Albrechtsen: Department of Clinical Biochemistry, Copenhagen University Hospital – Bispebjerg, Copenhagen, Denmark

Dr Wewer Albrechtsen is a consultant and Associate Professor and has worked for more than 10 years in the field of glucagon-like peptides, in particular their relevance to metabolic diseases. He was trained by Prof Jens Juul Holst and has since developed his own laboratory, in which he and his group focus on translational hormonal research in the context of diabetes, obesity and NAFLD. Dr Wewer Albrechtsen is interested in the pathophysiological and clinical implications of glucagon-like peptides, how to measure them accurately, how they appear to have multiorgan effects and how they signal through G-protein Coupled Receptors.
 

Flávio Adsuara Cadegiani: Corpometria Institute, Brasilia, Brazil

Dr Flavio Cadegiani is a board-certified endocrinologist with PhD in Clinical Endocrinology at Federal University of São Paulo. Focused on the use of GLP-1 analogues alone or combination with other drug classes and publication of the results of his center. 


 

Victor Gault: Ulster University, Northern Ireland, United Kingdom

Professor Victor Gault is currently Professor of Experimental Medicine and Associate Dean for Research and Innovation at Ulster University. He studied biochemistry at Queen’s University Belfast and obtained his PhD in diabetes and endocrinology from Ulster University. His research interests focus on the biochemical and physiological function of gut-derived hormones and bioengineered forms in healthy and diseased states, with particular emphasis on the potential role of gut peptides in the treatment of diabetes, obesity and associated neurodegenerative disorders. Professor Gault is the holder of international patents/patent families for novel diabetes therapeutics and is a member of several professional societies, national and international committees, and Editorial Boards.